Magazine Article | March 1, 2022

Is Biopharma At An Inflection Point Regarding Digital Transformation?

Source: Life Science Leader

By Dan Schell, Chief Editor, Clinical Leader

Whenever someone brings up the topic of change, especially in relation to the pandemic, inevitably there is some mention of the word technology, too (e.g., Zoom calls). If we're talking about the biopharma industry, then usually conversations including these two words also are peppered with terms like slow or late adopter. Sure, there are plenty of exceptions to this rule, but overall, we're not exactly known to be cutting edge in terms of technology adoption. But according to a recent report by Deloitte, that sentiment may be changing.

access the Magazine Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader